SECsense Logo

Myriad Genetics, Inc. 8-K Report: Key Insights & Stock Update

$MYGN
Form 8-K
Filed on: 2025-01-15
Source
Myriad Genetics, Inc. 8-K Report: Key Insights & Stock Update

From the provided section of the financial report, here are the key insights:

  1. Company Information:
  • Name: Myriad Genetics, Inc.
  • CIK: 0000899923
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 0-26642
  • EIN: 87-0494517
  • Address: 322 North 2200 West, Salt Lake City, UT 84116
  • Phone Number: 801-584-3600
  1. Filing Type:
  • Form Type: 8-K (Current Report)
  • Filing Date: January 15, 2025
  1. Stock Information:
  • Type of Stock: Common Stock
  • Par Value: $0.01
  • Ticker Symbol: MYGN
  • Exchange: NASDAQ
  1. Period of Reporting:
  • Reporting Period Start Date: January 15, 2025
  • Reporting Period End Date: January 15, 2025

Summary:

This financial report section indicates that Myriad Genetics, Inc. filed an 8-K report on January 15, 2025, concerning a significant event or information that could affect its stock performance. The company is based in Salt Lake City, Utah, and is publicly traded on the NASDAQ under the ticker MYGN. The document reflects a snapshot of the company's registration and reporting obligations with the SEC.